These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 15956785

  • 41. Properties of rabbit liver aldehyde oxidase and the relationship of the enzyme to xanthine oxidase and dehydrogenase.
    Turner NA, Doyle WA, Ventom AM, Bray RC.
    Eur J Biochem; 1995 Sep 01; 232(2):646-57. PubMed ID: 7556219
    [Abstract] [Full Text] [Related]

  • 42. Identification of aldehyde oxidase as the neonicotinoid nitroreductase.
    Dick RA, Kanne DB, Casida JE.
    Chem Res Toxicol; 2005 Feb 01; 18(2):317-23. PubMed ID: 15720138
    [Abstract] [Full Text] [Related]

  • 43. Zebularine metabolism by aldehyde oxidase in hepatic cytosol from humans, monkeys, dogs, rats, and mice: influence of sex and inhibitors.
    Klecker RW, Cysyk RL, Collins JM.
    Bioorg Med Chem; 2006 Jan 01; 14(1):62-6. PubMed ID: 16143537
    [Abstract] [Full Text] [Related]

  • 44. Aldehyde oxidase-dependent species difference in hepatic metabolism of fasudil to hydroxyfasudil.
    Mao Z, Wu Y, Li Q, Wang X, Liu Y, Di X.
    Xenobiotica; 2018 Feb 01; 48(2):170-177. PubMed ID: 28166443
    [Abstract] [Full Text] [Related]

  • 45. Aldehyde oxidase activity and inhibition in hepatocytes and cytosolic fractions from mouse, rat, monkey and human.
    Sahi J, Khan KK, Black CB.
    Drug Metab Lett; 2008 Aug 01; 2(3):176-83. PubMed ID: 19356090
    [Abstract] [Full Text] [Related]

  • 46. Nitrite reductase activity of rat and human xanthine oxidase, xanthine dehydrogenase, and aldehyde oxidase: evaluation of their contribution to NO formation in vivo.
    Maia LB, Pereira V, Mira L, Moura JJ.
    Biochemistry; 2015 Jan 27; 54(3):685-710. PubMed ID: 25537183
    [Abstract] [Full Text] [Related]

  • 47. A new aldehyde oxidase catalyzing the conversion of glycolaldehyde to glycolate from Burkholderia sp. AIU 129.
    Yamada M, Adachi K, Ogawa N, Kishino S, Ogawa J, Kataoka M, Shimizu S, Isobe K.
    J Biosci Bioeng; 2015 Apr 27; 119(4):410-5. PubMed ID: 25283808
    [Abstract] [Full Text] [Related]

  • 48. Zonal distribution of allopurinol-oxidizing enzymes in rat liver.
    Moriwaki Y, Yamamoto T, Yamakita J, Takahashi S, Tsutsumi Z, Higashino K.
    Adv Exp Med Biol; 1998 Apr 27; 431():47-50. PubMed ID: 9598029
    [Abstract] [Full Text] [Related]

  • 49. Substrate specificity of human liver aldehyde oxidase toward substituted quinazolines and phthalazines: a comparison with hepatic enzyme from guinea pig, rabbit, and baboon.
    Beedham C, Critchley DJ, Rance DJ.
    Arch Biochem Biophys; 1995 Jun 01; 319(2):481-90. PubMed ID: 7786031
    [Abstract] [Full Text] [Related]

  • 50. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase.
    Itoh K, Yamamura M, Takasaki W, Sasaki T, Masubuchi A, Tanaka Y.
    Biopharm Drug Dispos; 2006 Apr 01; 27(3):133-9. PubMed ID: 16400710
    [Abstract] [Full Text] [Related]

  • 51. Genetic polymorphism of aldehyde oxidase in Donryu rats.
    Itoh K, Masubuchi A, Sasaki T, Adachi M, Watanabe N, Nagata K, Yamazoe Y, Hiratsuka M, Mizugaki M, Tanaka Y.
    Drug Metab Dispos; 2007 May 01; 35(5):734-9. PubMed ID: 17293383
    [Abstract] [Full Text] [Related]

  • 52. [Research advances in non-P450-mediated drug oxidative metabolism].
    Zhou L, Zhong DF, Chen XY.
    Yao Xue Xue Bao; 2017 Jan 01; 52(1):8-18. PubMed ID: 29911369
    [Abstract] [Full Text] [Related]

  • 53. Metabolism of cryptolepine and 2-fluorocryptolepine by aldehyde oxidase.
    Stell JG, Wheelhouse RT, Wright CW.
    J Pharm Pharmacol; 2012 Feb 01; 64(2):237-43. PubMed ID: 22221099
    [Abstract] [Full Text] [Related]

  • 54. In vitro oxidation of pyrazinamide and allopurinol by rat liver aldehyde oxidase.
    Moriwaki Y, Yamamoto T, Nasako Y, Takahashi S, Suda M, Hiroishi K, Hada T, Higashino K.
    Biochem Pharmacol; 1993 Sep 14; 46(6):975-81. PubMed ID: 8216357
    [Abstract] [Full Text] [Related]

  • 55. [Biogenic amines in the pathogenesis of different forms of viral infections].
    Popenenkova ZA, Maslennikov GA.
    Vestn Akad Med Nauk SSSR; 1977 Sep 14; (7):83-92. PubMed ID: 197741
    [No Abstract] [Full Text] [Related]

  • 56. Evaluation of vanillin as a probe drug for aldehyde oxidase and phenotyping for its activity in a Western Indian Cohort.
    Subash S, Gogtay NJ, Iyer KR, Gandhe P, Budania R, Thatte UM.
    Indian J Pharmacol; 2021 Sep 14; 53(3):213-220. PubMed ID: 34169906
    [Abstract] [Full Text] [Related]

  • 57. Developmental changes of aldehyde oxidase in postnatal rat liver.
    Tayama Y, Moriyasu A, Sugihara K, Ohta S, Kitamura S.
    Drug Metab Pharmacokinet; 2007 Apr 14; 22(2):119-24. PubMed ID: 17495419
    [Abstract] [Full Text] [Related]

  • 58. Diurnal variation and melatonin induction of hepatic molybdenum hydroxylase activity in the guinea-pig.
    Beedham C, Padwick DJ, al-Tayib Y, Smith JA.
    Biochem Pharmacol; 1989 May 01; 38(9):1459-64. PubMed ID: 2719720
    [Abstract] [Full Text] [Related]

  • 59. Side-chain metabolism of propranolol: involvement of monoamine oxidase and aldehyde reductase in the metabolism of N-desisopropylpropranolol to propranolol glycol in rat liver.
    Wu X, Noda A, Noda H, Imamura Y.
    Comp Biochem Physiol C Toxicol Pharmacol; 2001 Aug 01; 129(4):361-8. PubMed ID: 11489433
    [Abstract] [Full Text] [Related]

  • 60. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene.
    Tanoue C, Sugihara K, Tayama Y, Uramaru N, Watanabe Y, Ohta S, Kitamura S.
    Drug Metab Lett; 2017 Aug 01; 10(4):278-285. PubMed ID: 28029084
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.